354 related articles for article (PubMed ID: 33917455)
1. Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions.
Wallis DJ; Truong L; La Du J; Tanguay RL; Reif DM
Toxics; 2021 Apr; 9(4):. PubMed ID: 33917455
[TBL] [Abstract][Full Text] [Related]
2. DEDuCT 2.0: An updated knowledgebase and an exploration of the current regulations and guidelines from the perspective of endocrine disrupting chemicals.
Karthikeyan BS; Ravichandran J; Aparna SR; Samal A
Chemosphere; 2021 Mar; 267():128898. PubMed ID: 33190914
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
[TBL] [Abstract][Full Text] [Related]
4. Methodological issues in human studies of endocrine disrupting chemicals.
Lee DH; Jacobs DR
Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
[TBL] [Abstract][Full Text] [Related]
5. An inadvertent issue of human retina exposure to endocrine disrupting chemicals: A safety assessment.
Li M; Yang T; Gao L; Xu H
Chemosphere; 2021 Feb; 264(Pt 1):128484. PubMed ID: 33022499
[TBL] [Abstract][Full Text] [Related]
6. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
[TBL] [Abstract][Full Text] [Related]
7. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
8. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
[TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
Smith CJ; Perfetti TA; Hayes AW; Berry SC
Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
[TBL] [Abstract][Full Text] [Related]
10. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
11. Endocrine disrupting chemical Bisphenol A and its potential effects on female health.
Kawa IA; Akbar Masood ; Fatima Q; Mir SA; Jeelani H; Manzoor S; Rashid F
Diabetes Metab Syndr; 2021; 15(3):803-811. PubMed ID: 33839640
[TBL] [Abstract][Full Text] [Related]
12. In utero exposure to endocrine disruptors and developmental neurotoxicity: Implications for behavioural and neurological disorders in adult life.
Raja GL; Subhashree KD; Kantayya KE
Environ Res; 2022 Jan; 203():111829. PubMed ID: 34358505
[TBL] [Abstract][Full Text] [Related]
13. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
14. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disruptors: present issues, future directions.
Crews D; Willingham E; Skipper JK
Q Rev Biol; 2000 Sep; 75(3):243-60. PubMed ID: 11008698
[TBL] [Abstract][Full Text] [Related]
16. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Arch Toxicol; 2020 Jul; 94(7):2549-2557. PubMed ID: 32514609
[TBL] [Abstract][Full Text] [Related]
17. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
[TBL] [Abstract][Full Text] [Related]
18. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional analysis of endocrine disruption using zebrafish and massively parallel sequencing.
Baker ME; Hardiman G
J Mol Endocrinol; 2014 Jun; 52(3):R241-56. PubMed ID: 24850832
[TBL] [Abstract][Full Text] [Related]
20. Endocrine-Disrupting Chemicals and Their Effects in Pet Dogs and Cats: An Overview.
Pocar P; Grieco V; Aidos L; Borromeo V
Animals (Basel); 2023 Jan; 13(3):. PubMed ID: 36766267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
